BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 28631404)

  • 21. Different functional connectivity modes of the right fronto-insular cortex in akinetic-rigid and tremor-dominant Parkinson's disease.
    Wang J; Shen Y; Peng J; Wang A; Wu X; Chen X; Liu J; Wei M; Zou D; Han Y; Cheng O
    Neurol Sci; 2021 Jul; 42(7):2937-2946. PubMed ID: 33236247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.
    Dirkx MF; Zach H; van Nuland A; Bloem BR; Toni I; Helmich RC
    Brain; 2019 Oct; 142(10):3144-3157. PubMed ID: 31509182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axonal degeneration in Parkinson's disease - Basal ganglia circuitry and D2 receptor availability.
    Pelzer EA; Melzer C; Schönberger A; Hess M; Timmermann L; Eggers C; Tittgemeyer M
    Neuroimage Clin; 2019; 23():101906. PubMed ID: 31254937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?
    Gerasimou G; Costa DC; Papanastasiou E; Bostanjiopoulou S; Arnaoutoglou M; Moralidis E; Aggelopoulou T; Gotzamani-Psarrakou A
    Ann Nucl Med; 2012 May; 26(4):337-44. PubMed ID: 22382608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered striatal circuits underlie characteristic personality traits in Parkinson's disease.
    Ishii T; Sawamoto N; Tabu H; Kawashima H; Okada T; Togashi K; Takahashi R; Fukuyama H
    J Neurol; 2016 Sep; 263(9):1828-39. PubMed ID: 27334907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
    Benamer HT; Patterson J; Wyper DJ; Hadley DM; Macphee GJ; Grosset DG
    Mov Disord; 2000 Jul; 15(4):692-8. PubMed ID: 10928580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal ventral tegmental area-anterior cingulate cortex connectivity in Parkinson's disease with depression.
    Wei L; Hu X; Yuan Y; Liu W; Chen H
    Behav Brain Res; 2018 Jul; 347():132-139. PubMed ID: 29530489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.
    Barbagallo G; Arabia G; Morelli M; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A; Caracciolo M; Sabatini U; Cherubini A; Quattrone A
    Parkinsonism Relat Disord; 2017 Oct; 43():78-84. PubMed ID: 28774469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
    Mito Y; Yabe I; Yaguchi H; Takei T; Terae S; Tajima Y
    Parkinsonism Relat Disord; 2018 May; 50():37-41. PubMed ID: 29449184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study.
    Guan X; Xuan M; Gu Q; Xu X; Huang P; Wang N; Shen Z; Xu J; Luo W; Zhang M
    J Magn Reson Imaging; 2017 May; 45(5):1335-1342. PubMed ID: 27545971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease patients show reduced cortical-subcortical sensorimotor connectivity.
    Sharman M; Valabregue R; Perlbarg V; Marrakchi-Kacem L; Vidailhet M; Benali H; Brice A; Lehéricy S
    Mov Disord; 2013 Apr; 28(4):447-54. PubMed ID: 23144002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Brain Alterations in Motor Subtypes of Parkinson's Disease: Evidence from Probabilistic Tractography and Shape Analysis.
    Vervoort G; Leunissen I; Firbank M; Heremans E; Nackaerts E; Vandenberghe W; Nieuwboer A
    PLoS One; 2016; 11(6):e0157743. PubMed ID: 27314952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced neural connectivity but increased task-related activity during working memory in de novo Parkinson patients.
    Trujillo JP; Gerrits NJ; Veltman DJ; Berendse HW; van der Werf YD; van den Heuvel OA
    Hum Brain Mapp; 2015 Apr; 36(4):1554-66. PubMed ID: 25598397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.
    Petersen K; Van Wouwe N; Stark A; Lin YC; Kang H; Trujillo-Diaz P; Kessler R; Zald D; Donahue MJ; Claassen DO
    Hum Brain Mapp; 2018 Jan; 39(1):509-521. PubMed ID: 29086460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine transporter imaging in essential tremor with and without parkinsonian features.
    Waln O; Wu Y; Perlman R; Wendt J; Van AK; Jankovic J
    J Neural Transm (Vienna); 2015 Nov; 122(11):1515-21. PubMed ID: 26133163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease.
    Moccia M; Pappatà S; Picillo M; Erro R; Coda AR; Longo K; Vitale C; Amboni M; Brunetti A; Capo G; Salvatore M; Barone P; Pellecchia MT
    J Neurol; 2014 Nov; 261(11):2112-8. PubMed ID: 25119838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal dopamine transporter abnormalities in patients with essential tremor.
    Isaias IU; Canesi M; Benti R; Gerundini P; Cilia R; Pezzoli G; Antonini A
    Nucl Med Commun; 2008 Apr; 29(4):349-53. PubMed ID: 18317299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
    Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A
    Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.